CytoVale

About:

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Website: http://www.cytovale.com/

Twitter/X: cytovale

Top Investors: Alumni Ventures, National Science Foundation, Norwest Venture Partners, Sands Capital Ventures, CPP Investments

Description:

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases, revolutionizing diagnostics using cell mechanics and machine learning. The company was founded in 2013 by Ajay Shah and Dino Di Carlo and is based in San Francisco, California.

Total Funding Amount:

$229M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)cytovale.com

Founders:

Ajay Shah, Dino Di Carlo

Number of Employees:

11-50

Last Funding Date:

2024-10-10

IPO Status:

Private

Industries: